GMG has confirmed its plans to further expand its health-related business as the industry undergoes an unprecedented transformation
The conglomerate’s health vertical is on track to expand its retail footprint in the UAE by more than 40% by the end of 2022.
The health industry has experienced a paradigm shift from curative to preventative care during the COVID-19 pandemic. More consumers are changing their approach to fitness and wellbeing. According to a recent industry report, healthcare expenditure across the GCC will touch US$89bn by 2022. Another global survey recently revealed changing consumer habits, with 62% of individuals saying that they have made significant lifestyle changes towards improving their health. Approximately one in three say they’re eating healthier food, while 28% say they have increased their exercise frequency during the pandemic.
GMG’s health business is in turn gearing up for a surge in consumer demand for quality health and wellbeing products and services. The company’s health portfolio currently includes prominent homegrown concepts like supercare Pharmacy, Good Health and Arabella Pharmacy.
Mohammad A Baker, deputy chairman and CEO of GMG, said, “The healthcare industry in the UAE and the wider Middle East region is transforming at a rapid pace, with consumer behaviour shifting towards preventative care. Through our diversified portfolio of health concepts, GMG is ensuring that we take proactive steps to fulfil growing consumer needs while inspiring good health and wellbeing. With our expansion, we are continuing to contribute to the development of the UAE society, in line with its national ambition of building a world-class healthcare industry.”
Over the last several years, GMG has been expanding its global operations with a diversified portfolio of brands that now covers industries such as sports, food and health. GMG has introduced more than 90 brands into the Middle East while also creating reliable and quality-driven homegrown brands.
